Astellas Pharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-07-20
Share capital
50 000,00 PLN
Activity description

Astellas Pharma is a global life sciences company headquartered in Tokyo, operating in more than 70 countries and areas. It develops therapies in oncology, ophthalmology, urology, immunology and women's health, and conducts research into diseases with high unmet medical need.

Registered address
ul. Żwirki I Wigury 16C, 02-092 Warszawa, Poland
Website
astellas.comWebsite active
Phone
Electronic delivery address
AE:PL-96815-96314-HUCAE-27

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2026.

Results vs industry

Revenue
This companyUSD 220.20mMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 2.90mMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 215.89mMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 146.99mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 1999-03-12. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 265.5K

Public aid

No public aid cases recorded in the last 10 years.

Tenders

327 tenders recorded as contractor: 31 national ($1,957,014) and 296 EU ($3,563,717,624).

SubjectAmount
Dostawa różnych produktów leczniczych, w tym cytostatyków, produktów leczniczych z programów lekowych i akcesoriów do receptury dla Copernicus PL Sp. z o.o.
–
Dostawa leków do chemioterapii i programów lekowych 2026-2028
–
Zakup i dostawa produktów farmaceutycznych II
–

Public sector contracts

Astellas Pharma is the contractor in 34 public sector contracts, worth PLN 43.76m in total. They were signed with 22 public buyers.

Public buyerValue
Zespół Opieki Zdrowotnej w Suchej BeskidzkiejPLN 73,103
Specjalistyczny Szpital Miejski Im.Mikołaja KopernikaPLN 56,481
Uniwersytecki Szpital Kliniczny w PoznaniuPLN 26,984
Samodzielny Publiczny Szpital Wojewódzki Im. Papieża Jana Pawła II w ZamościuPLN 39,435
Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych I Administracji w KoszaliniePLN 240.64

Trademarks

Astellas Pharma currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2005.

MarkProtected until
NANOMASAŻ(word)–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Katarzyna Agnieszka Sińska – Management Board Member
Giuseppe Maduri – Management Board Member
Nilay Tarr – President of the Management Board

Manner of representation

Two members of the management board acting jointly.

Ownership

OwnerSharesShare valueStake
Astellas Pharma Europe Ltd.
100$13,506.21100%

Beneficial owners

Person

Competitors

Name
Novartis Polandsp. z o.o.
MSD Polska Dystrybucjasp. z o.o.
Pfizer Trading Polskasp. z o.o.
Bristol-Myers Squibb Polskasp. z o.o.
Takeda Pharmasp. z o.o.
Gilead Sciences Polandsp. z o.o.
Amgensp. z o.o.
Angelini Pharma Polskasp. z o.o.
Magnapharm Polandsp. z o.o.
Chiesi Polandsp. z o.o.

Change history

DateEvent
2022-10-07Address change
2012-09-28Address change
2005-08-02Name change
2004-02-11Share capital change
2001-07-20Entered in the register

FAQ

Last updated: 2026-10-12